NMRA
Neumora Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.31
−2.96%0
Insider buys (3m)
11
Insider sells (3m)
-$701.6K
Net value (3m)
-19.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 67,741 | $1.51 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 67,741 | $0.72 |
| Aug 21, 2026 | Pinto Joshua · director, officer: President & CEO | A-Award | 500,000 | $1.52 |
| Aug 21, 2026 | Milligan Michael Lee · officer: See Remarks | A-Award | 175,000 | $1.52 |
| Aug 21, 2026 | Duncan Jason · officer: See Remarks | A-Award | 375,000 | $1.52 |
| Aug 21, 2026 | BERNS PAUL L · director, officer: See Remarks | A-Award | 500,000 | $1.52 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | A-Award | 200,000 | $1.52 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 21,055 | $1.60 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 21,055 | $0.72 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 20,553 | $1.59 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 20,553 | $0.72 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 66,711 | $1.51 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 45,026 | $0.72 |
| Aug 21, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 21,685 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 1,424 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 30,918 | $1.65 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 30,918 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 31,000 | $1.65 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 17,732 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 13,268 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 34,987 | $1.59 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 34,987 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 34,162 | $1.58 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 34,162 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 55,016 | $1.50 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 29,737 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 25,279 | $0.72 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 34,020 | $1.49 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | Sale | 57,670 | $1.51 |
| Aug 19, 2026 | Aurora Daljit Singh · officer: See Remarks | M-Exempt | 1 | $0.72 |
Institutional positioning
13F filings over the trailing two quarters
New 25Increased 35Reduced 35Sold out 114
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SIREN, L.L.C. | Increased | 8,497,822 | May 14, 2026 |
| SOFTBANK GROUP CORP. | Reduced | 6,090,301 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | New Position | 5,104,097 | May 29, 2026 |
| MIC CAPITAL MANAGEMENT UK LLP | Unchanged | 4,460,700 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,891,893 | May 15, 2026 |
| FMR LLC | Increased | 3,498,658 | May 15, 2026 |
| WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST | Unchanged | 3,309,123 | Apr 22, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 2,754,854 | May 15, 2026 |
| ICONIQ CAPITAL, LLC | Unchanged | 2,559,090 | May 15, 2026 |
| LUNATE CAPITAL LTD | Unchanged | 2,124,143 | Apr 16, 2026 |
| BLACKROCK, INC. | Increased | 2,054,316 | May 13, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 2,036,692 | May 15, 2026 |
| JOHNSON & JOHNSON | Reduced | 1,849,445 | May 13, 2026 |
| JOHNSON & JOHNSON | Unchanged | 1,849,445 | Mar 18, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,525,341 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 21, 2026